+1 (704) 266-3234
+1 (704) 266-3234You are here :
Published on: Jan 2024 | From USD $3660 | Published By: LP INFORMATION INC | Number Of Pages: 108
According to our LPI (LP Information) latest study, the global mRNA Cancer Vaccines and Therapeutics market size was valued at US$ 137.3 million in 2023. With growing demand in downstream market, the mRNA Cancer Vaccines and Therapeutics is forecast to a readjusted size of US$ 483.9 million by 2030 with a CAGR of 19.7% during review period.
The research report highlights the growth potential of the global mRNA Cancer Vaccines and Therapeutics market. mRNA Cancer Vaccines and Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of mRNA Cancer Vaccines and Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the mRNA Cancer Vaccines and Therapeutics market.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
Key Features:
The report on mRNA Cancer Vaccines and Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the mRNA Cancer Vaccines and Therapeutics market. It may include historical data, market segmentation by Type (e.g., Adeno Carcinomas, Mucinous Carcinomas), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the mRNA Cancer Vaccines and Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the mRNA Cancer Vaccines and Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the mRNA Cancer Vaccines and Therapeutics industry. This include advancements in mRNA Cancer Vaccines and Therapeutics technology, mRNA Cancer Vaccines and Therapeutics new entrants, mRNA Cancer Vaccines and Therapeutics new investment, and other innovations that are shaping the future of mRNA Cancer Vaccines and Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the mRNA Cancer Vaccines and Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for mRNA Cancer Vaccines and Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the mRNA Cancer Vaccines and Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting mRNA Cancer Vaccines and Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the mRNA Cancer Vaccines and Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the mRNA Cancer Vaccines and Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the mRNA Cancer Vaccines and Therapeutics market.
Market Segmentation:
mRNA Cancer Vaccines and Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
Segmentation by application
Infectious Disease
Cancer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global mRNA Cancer Vaccines and Therapeutics Market Size 2019-2030
2.1.2 mRNA Cancer Vaccines and Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 mRNA Cancer Vaccines and Therapeutics Segment by Type
2.2.1 Adeno Carcinomas
2.2.2 Mucinous Carcinomas
2.2.3 Adenosquamous Carcinomas
2.3 mRNA Cancer Vaccines and Therapeutics Market Size by Type
2.3.1 mRNA Cancer Vaccines and Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2019-2024)
2.4 mRNA Cancer Vaccines and Therapeutics Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.4.3 Others
2.5 mRNA Cancer Vaccines and Therapeutics Market Size by Application
2.5.1 mRNA Cancer Vaccines and Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2019-2024)
3 mRNA Cancer Vaccines and Therapeutics Market Size by Player
3.1 mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Players
3.1.1 Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2019-2024)
3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Cancer Vaccines and Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 mRNA Cancer Vaccines and Therapeutics by Regions
4.1 mRNA Cancer Vaccines and Therapeutics Market Size by Regions (2019-2024)
4.2 Americas mRNA Cancer Vaccines and Therapeutics Market Size Growth (2019-2024)
4.3 APAC mRNA Cancer Vaccines and Therapeutics Market Size Growth (2019-2024)
4.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Growth (2019-2024)
5 Americas
5.1 Americas mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024)
5.2 Americas mRNA Cancer Vaccines and Therapeutics Market Size by Type (2019-2024)
5.3 Americas mRNA Cancer Vaccines and Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Cancer Vaccines and Therapeutics Market Size by Region (2019-2024)
6.2 APAC mRNA Cancer Vaccines and Therapeutics Market Size by Type (2019-2024)
6.3 APAC mRNA Cancer Vaccines and Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics by Country (2019-2024)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2019-2024)
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics by Region (2019-2024)
8.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global mRNA Cancer Vaccines and Therapeutics Market Forecast
10.1 Global mRNA Cancer Vaccines and Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global mRNA Cancer Vaccines and Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas mRNA Cancer Vaccines and Therapeutics Forecast
10.1.3 APAC mRNA Cancer Vaccines and Therapeutics Forecast
10.1.4 Europe mRNA Cancer Vaccines and Therapeutics Forecast
10.1.5 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Forecast
10.2 Americas mRNA Cancer Vaccines and Therapeutics Forecast by Country (2025-2030)
10.2.1 United States mRNA Cancer Vaccines and Therapeutics Market Forecast
10.2.2 Canada mRNA Cancer Vaccines and Therapeutics Market Forecast
10.2.3 Mexico mRNA Cancer Vaccines and Therapeutics Market Forecast
10.2.4 Brazil mRNA Cancer Vaccines and Therapeutics Market Forecast
10.3 APAC mRNA Cancer Vaccines and Therapeutics Forecast by Region (2025-2030)
10.3.1 China mRNA Cancer Vaccines and Therapeutics Market Forecast
10.3.2 Japan mRNA Cancer Vaccines and Therapeutics Market Forecast
10.3.3 Korea mRNA Cancer Vaccines and Therapeutics Market Forecast
10.3.4 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Forecast
10.3.5 India mRNA Cancer Vaccines and Therapeutics Market Forecast
10.3.6 Australia mRNA Cancer Vaccines and Therapeutics Market Forecast
10.4 Europe mRNA Cancer Vaccines and Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany mRNA Cancer Vaccines and Therapeutics Market Forecast
10.4.2 France mRNA Cancer Vaccines and Therapeutics Market Forecast
10.4.3 UK mRNA Cancer Vaccines and Therapeutics Market Forecast
10.4.4 Italy mRNA Cancer Vaccines and Therapeutics Market Forecast
10.4.5 Russia mRNA Cancer Vaccines and Therapeutics Market Forecast
10.5 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt mRNA Cancer Vaccines and Therapeutics Market Forecast
10.5.2 South Africa mRNA Cancer Vaccines and Therapeutics Market Forecast
10.5.3 Israel mRNA Cancer Vaccines and Therapeutics Market Forecast
10.5.4 Turkey mRNA Cancer Vaccines and Therapeutics Market Forecast
10.5.5 GCC Countries mRNA Cancer Vaccines and Therapeutics Market Forecast
10.6 Global mRNA Cancer Vaccines and Therapeutics Forecast by Type (2025-2030)
10.7 Global mRNA Cancer Vaccines and Therapeutics Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Information
11.1.2 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offered
11.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Moderna Therapeutics Main Business Overview
11.1.5 Moderna Therapeutics Latest Developments
11.2 CureVac
11.2.1 CureVac Company Information
11.2.2 CureVac mRNA Cancer Vaccines and Therapeutics Product Offered
11.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 CureVac Main Business Overview
11.2.5 CureVac Latest Developments
11.3 Translate Bio
11.3.1 Translate Bio Company Information
11.3.2 Translate Bio mRNA Cancer Vaccines and Therapeutics Product Offered
11.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Translate Bio Main Business Overview
11.3.5 Translate Bio Latest Developments
11.4 BioNTech
11.4.1 BioNTech Company Information
11.4.2 BioNTech mRNA Cancer Vaccines and Therapeutics Product Offered
11.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 BioNTech Main Business Overview
11.4.5 BioNTech Latest Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Information
11.5.2 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offered
11.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sangamo Therapeutics Main Business Overview
11.5.5 Sangamo Therapeutics Latest Developments
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Information
11.6.2 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offered
11.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Argos Therapeutics Main Business Overview
11.6.5 Argos Therapeutics Latest Developments
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Information
11.7.2 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Offered
11.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 In-Cell-Art Main Business Overview
11.7.5 In-Cell-Art Latest Developments
11.8 eTheRNA
11.8.1 eTheRNA Company Information
11.8.2 eTheRNA mRNA Cancer Vaccines and Therapeutics Product Offered
11.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 eTheRNA Main Business Overview
11.8.5 eTheRNA Latest Developments
11.9 Ethris
11.9.1 Ethris Company Information
11.9.2 Ethris mRNA Cancer Vaccines and Therapeutics Product Offered
11.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Ethris Main Business Overview
11.9.5 Ethris Latest Developments
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Information
11.10.2 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Offered
11.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Tiba Biotechnology Main Business Overview
11.10.5 Tiba Biotechnology Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. mRNA Cancer Vaccines and Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Adeno Carcinomas
Table 3. Major Players of Mucinous Carcinomas
Table 4. Major Players of Adenosquamous Carcinomas
Table 5. mRNA Cancer Vaccines and Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2019-2024)
Table 8. mRNA Cancer Vaccines and Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2019-2024)
Table 11. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Player (2019-2024)
Table 13. mRNA Cancer Vaccines and Therapeutics Key Players Head office and Products Offered
Table 14. mRNA Cancer Vaccines and Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global mRNA Cancer Vaccines and Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Regions (2019-2024)
Table 19. Global mRNA Cancer Vaccines and Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Country (2019-2024)
Table 23. Americas mRNA Cancer Vaccines and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2019-2024)
Table 25. Americas mRNA Cancer Vaccines and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2019-2024)
Table 27. APAC mRNA Cancer Vaccines and Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Region (2019-2024)
Table 29. APAC mRNA Cancer Vaccines and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2019-2024)
Table 31. APAC mRNA Cancer Vaccines and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2019-2024)
Table 33. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Country (2019-2024)
Table 35. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2019-2024)
Table 37. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of mRNA Cancer Vaccines and Therapeutics
Table 46. Key Market Challenges & Risks of mRNA Cancer Vaccines and Therapeutics
Table 47. Key Industry Trends of mRNA Cancer Vaccines and Therapeutics
Table 48. Global mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Moderna Therapeutics Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors
Table 53. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offered
Table 54. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Moderna Therapeutics Main Business
Table 56. Moderna Therapeutics Latest Developments
Table 57. CureVac Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors
Table 58. CureVac mRNA Cancer Vaccines and Therapeutics Product Offered
Table 59. CureVac Main Business
Table 60. CureVac mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. CureVac Latest Developments
Table 62. Translate Bio Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors
Table 63. Translate Bio mRNA Cancer Vaccines and Therapeutics Product Offered
Table 64. Translate Bio Main Business
Table 65. Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Translate Bio Latest Developments
Table 67. BioNTech Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors
Table 68. BioNTech mRNA Cancer Vaccines and Therapeutics Product Offered
Table 69. BioNTech Main Business
Table 70. BioNTech mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. BioNTech Latest Developments
Table 72. Sangamo Therapeutics Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors
Table 73. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offered
Table 74. Sangamo Therapeutics Main Business
Table 75. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Sangamo Therapeutics Latest Developments
Table 77. Argos Therapeutics Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors
Table 78. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offered
Table 79. Argos Therapeutics Main Business
Table 80. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Argos Therapeutics Latest Developments
Table 82. In-Cell-Art Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors
Table 83. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Offered
Table 84. In-Cell-Art Main Business
Table 85. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. In-Cell-Art Latest Developments
Table 87. eTheRNA Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors
Table 88. eTheRNA mRNA Cancer Vaccines and Therapeutics Product Offered
Table 89. eTheRNA Main Business
Table 90. eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. eTheRNA Latest Developments
Table 92. Ethris Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors
Table 93. Ethris mRNA Cancer Vaccines and Therapeutics Product Offered
Table 94. Ethris Main Business
Table 95. Ethris mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Ethris Latest Developments
Table 97. Tiba Biotechnology Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors
Table 98. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Offered
Table 99. Tiba Biotechnology Main Business
Table 100. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Tiba Biotechnology Latest Developments
List of Figures
Figure 1. mRNA Cancer Vaccines and Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. mRNA Cancer Vaccines and Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. mRNA Cancer Vaccines and Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. mRNA Cancer Vaccines and Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type in 2023
Figure 10. mRNA Cancer Vaccines and Therapeutics in Infectious Disease
Figure 11. Global mRNA Cancer Vaccines and Therapeutics Market: Infectious Disease (2019-2024) & ($ Millions)
Figure 12. mRNA Cancer Vaccines and Therapeutics in Cancer
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Market: Cancer (2019-2024) & ($ Millions)
Figure 14. mRNA Cancer Vaccines and Therapeutics in Others
Figure 15. Global mRNA Cancer Vaccines and Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 16. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas mRNA Cancer Vaccines and Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC mRNA Cancer Vaccines and Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe mRNA Cancer Vaccines and Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas mRNA Cancer Vaccines and Therapeutics Value Market Share by Country in 2023
Figure 24. United States mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application in 2023
Figure 31. China mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country mRNA Cancer Vaccines and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries mRNA Cancer Vaccines and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share Forecast by Application (2025-2030)
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
In-depth database
Our Report’s database covers almost all topics of all regions over the Globe..
Recognised publishing sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales support.
Safe & Secure
Complete secure payment process.
: sales@marketintelligencedata.com
: 1137 waynewood dr,Waxhaw NC 28173 ,United States
: +1 (704) 266-3234
